Marco Lanza

Statistics

Publications

Citations

639

H-Index

Active since

1993

Affiliations

European Centre for Theoretical Studies in Nuclear Physics and Related Areas(Current)

University of Siena

University of Modena and Reggio Emilia

University of Genoa

Azienda Ospedaliera di Valtellina e Valchiavenna

Marco Lanza is an author at European Centre for Theoretical Studies in Nuclear Physics and Related Areas specializing in pharmacology, neuropharmacology, and medicine.

ORCID

Publications per year

1993–2018

Publications

CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex

Marco Lanza, Anna Fassio, Anita Gemignani et al. · European Journal of Pharmacology · 1993 · 75 citations

Life Sciences, Neuroscience, Pharmacology +17

Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression

Tiziana Piepoli, Laura Mennuni, S. Zerbi et al. · Osteoarthritis and Cartilage · 2009 · 62 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis

Riccardo Chiusaroli, Marcella Visentini, Chiara Galimberti et al. · Osteoarthritis and Cartilage · 2013 · 55 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +6

Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a γ-aminobutyric acidB (GABAB) receptor subtype

Mario Pende, Marco Lanza, Giambattista Bonanno et al. · Brain Research · 1993 · 54 citations

Life Sciences, Neurobiology, Neuroscience +17

Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain

Marco Lanza, Ferrari, Fiorentino et al. · Journal of Pain Research · 2011 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–5 of 19